Back
Theriva Biologics Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
46
TOVX
Theriva Biologics
Last Price:
$1.39
Seasonality Move:
360.99%
Buy
66
SRPT
Sarepta Therapeutics
Last Price:
$61.83
Seasonality Move:
13.61%
Sell
46
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
-
The current Theriva Biologics [TOVX] share price is $1.41. The Score for TOVX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
TOVX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $61.51. The Score for SRPT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.41The current trend is moderately bullish and TOVX is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $61.51The current trend is relatively stagnant and SRPT is experiencing slight buying pressure.
TOVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 58.6 | Buy |
Chaikin Money Flow: | -31 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.11 - 1.37) | Buy |
Bollinger Bands (100): | (1.18 - 1.54) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.32 | Sell |
Relative Strength Index (14 RSI): | 45.08 | Sell |
Chaikin Money Flow: | 186733 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.36 - 67.6) | Buy |
Bollinger Bands (100): | (74.34 - 126.84) | Sell |
TOVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.38 | Buy |
20-day SMA: | 1.25 | Buy |
50-day SMA: | 1.3 | Buy |
200-day SMA: | 2.35 | Sell |
8-day EMA: | 1.38 | Buy |
20-day EMA: | 1.31 | Buy |
50-day EMA: | 1.31 | Buy |
200-day EMA: | 3.03 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.18 | Buy |
20-day SMA: | 56.72 | Buy |
50-day SMA: | 79.93 | Sell |
200-day SMA: | 115.66 | Sell |
8-day EMA: | 59.01 | Buy |
20-day EMA: | 61.21 | Buy |
50-day EMA: | 75.93 | Sell |
200-day EMA: | 105.4 | Sell |
Theriva Biologics Earnings Growth & TOVX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.60 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.
Theriva Biologics Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |